Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Olympus Corporation of the Americas
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has an air leak present on day 7 after lobectomy, segmentectomy, or lung volume reduction surgery (LVRS), or on day 5 if the air leak is 1) continuous, 2) present during normal inhalation phase of inspiration, or 3) present upon normal expiration and accompanied by subcutaneous emphysema or respiratory compromise
You may not be if
Air leak only on force exhalation or cough
Subject has significant active asthma, pneumonia, bacterial bronchitis or clinically significant bronchiectasis
Subject is unable to provide informed consent and there is no designated authority to sign for the incapacitated patient
Subject is not an appropriate candidate for, or unable to tolerate, flexible bronchoscopy procedures
Subject has co-morbidities or factors that will prevent follow-up during the study period
Clareo Health | IBV Valve System for the Treatment of Prolonged Air Leak Under HDE H060002 - Post Approval Study
